Get started
Author

James F. Lynam

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
2018 · Kohei Shitara, Mustafa Özgüroğlu, et al. · The Lancet · 1,338
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
2022 · Jeanne Tie, Joshua D. Cohen, et al. · New England Journal of Medicine · 1,178
PDF
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
2020 · Thomas Powles, Michiel S van der Heijden, et al. · The Lancet Oncology · 518
PDF
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
2025 · Jeanne Tie, Yuxuan Wang, et al. · Nature Medicine · 118
Utility of selection methods for specialist medical training: A BEME (best evidence medical education) systematic review: BEME guide no. 45
2017 · Chris Roberts, Priya Khanna, et al. · Medical Teacher · 69
TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol
2019 · Jarad Martin, Paul Keall, et al. · BMJ Open · 36
PDF
Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab
2020 · Doan T. M. Ngo, Trent Williams, et al. · Journal of Clinical Medicine · 31
PDF
ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG).
2025 · Jeanne Tie, Yuxuan Wang, et al. · Journal of Clinical Oncology · 28
PDF
The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma
2023 · Mark Marsland, Amiee Dowdell, et al. · Cancers · 15
PDF
Understanding the value of brain donation for research to donors, next-of-kin and clinicians: A systematic review
2023 · Cassandra P. Griffin, Jenna R. Bowen, et al. · PLoS ONE · 12
PDF
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy
2023 · Amiee Dowdell, Mark Marsland, et al. · FASEB BioAdvances · 12
PDF
Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole
2021 · Cassandra P Griffin, Christine L Paul, et al. · Neuro-Oncology Advances · 12
PDF
Results of a survey of cancer patients’ willingness to travel to participate in a clinical trial
2019 · Nicholas Zdenkowski, James Lynam, et al. · Internal Medicine Journal · 12
First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty
2022 · Mark T. Nolan, Louise Creati, et al. · Heart Lung and Circulation · 11
Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer
2022 · Swetha Sridharan, Fiona Day, et al. · Radiation Oncology · 10
PDF
Adjuvant chemotherapy guided by circulating tumor DNA analysis in stage II colon cancer: The randomized DYNAMIC trial.
2022 · Jeanne Tie, Joshua Cohen, et al. · Journal of Clinical Oncology · 10
‘I think both of us drew strength from it’: qualitative reflections from next of kin following the death and post-mortem brain donation of a loved one with brain cancer
2024 · Cassandra P. Griffin, Melissa A. Carlson, et al. · Palliative Care and Social Practice · 8
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations
2023 · Ciara Conduit, Jeremy Lewin, et al. · JCO Oncology Practice · 8
ProNGF Expression and Targeting in Glioblastoma Multiforme
2023 · Mark Marsland, Amiee Dowdell, et al. · International Journal of Molecular Sciences · 8
PDF
LBA9 ctDNA-guided adjuvant chemotherapy de-escalation in stage III colon cancer: Primary analysis of the ctDNA-negative cohort from the randomized AGITG DYNAMIC-III trial (Intergroup study of AGITG and CCTG)
2025 · J. Tie, Y. Wang, et al. · Annals of Oncology · 7
The impact of brain cancer care coordinators on healthcare utilization and outcomes in patients with glioblastoma
2024 · Martin Hong, Lucy Leigh, et al. · Neuro-Oncology Practice · 7
A qualitative study investigating Australian cancer service outpatients’ experience of distress screening and management: what is the personal relevance, acceptability and improvement opportunities from patient perspectives?
2021 · Kristen McCarter, Melissa A. Carlson, et al. · Supportive Care in Cancer · 7
PDF
Business as unusual: medical oncology services adapt and deliver during COVID ‐19
2021 · Avraham Travers, Kim Adler, et al. · Internal Medicine Journal · 7
Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients
2018 · Surein Arulananda, James Lynam, et al. · Internal Medicine Journal · 7
PDF
Initial results from CLIMATE, a prospective cohort study assessing the clinical utility of miR-371a-3p (miR-371) as a marker of minimal residual disease (MRD) in clinical stage 1 testicular germ cell tumour (TGCT): ANZUP 1906.
2026 · Ben Tran, Jeremy Howard Lewin, et al. · Journal of Clinical Oncology · 6
Works count: 53
Citation count: 3,527
H-index: 12
I10-index: 16
Year
Topic
Type